Efficacy and safety of sorafenib in patients in theAsia-Pacific region with advanced hepatocellular carcinoma:a phase Ⅲ randomised,doubleblind,placebo-controlled trial .2 .张海亮,叶定伟,姚旭东,等,增加索拉非尼剂量治疗常规剂量无效的晚期肾癌的临床评价.中华泌尿外科杂志,2010,31.3 .郑建萍,刘振华,陈峥,等.常规及加量剂量的索 ......